• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    Edwards Lifesciences Corp. (EW)

    -NYSE
    135.65 Down 0.11(0.08%) Mar 5, 4:08PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Edwards Lifesciences Corp.
    One Edwards Way
    Irvine, CA 92614
    United States - Map
    Phone: 949-250-2500
    Website: http://www.edwards.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Appliances & Equipment
    Full Time Employees:9,100

    Business Summary 

    Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patient’s diseased or defective heart valve. In addition, it produces pericardial valves from biologically inert animal tissue; and provides heart valve repair therapies, including annuloplasty rings and systems. Further, the company offers critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function in surgical and intensive care settings; minimally invasive continuous cardiac output monitoring systems and non invasive hemodynamic monitor for real time beat-to-beat information; pulmonary artery catheters; continuous venous oximetry catheter for measuring central venous oxygen saturation; and sensor-catheter sets that measures a critically ill patient's volumetric hemodynamic parameters. Additionally, its critical care products include disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as embolectomy catheters for removing blood clots from peripheral blood vessels. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Edwards Lifesciences Corp.

    Corporate Governance 
    Edwards Lifesciences Corp.’s ISS Governance QuickScore as of Mar 1, 2015 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 7; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Michael A. Mussallem , 62
    Chairman and Chief Exec. Officer
    1.00M19.34M
    Mr. Donald E. Bobo Jr., 53
    Corp. VP of Heart Valve Therapy, Strategy & Corp. Devel.
    656.00K0.00
    Mr. Patrick B. Verguet , 57
    Corp. VP of Europe, Middle East & Africa
    962.00K1.48M
    Mr. Scott B. Ullem , 48
    Chief Financial Officer and Corp. VP
    N/AN/A
    Mr. Robert W. A. Sellers ,
    Principal Accounting Officer, VP and Corp. Controller
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders